| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |